secwatch.observer — SEC 8-K summary
======================================

Issuer:     iCoreConnect Inc. (—)
CIK:        0001906133
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001477932-24-002686
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

iCoreConnect receives Nasdaq deficiency notice after director resignation; cure period until May 2025
--------------------------------------------------------------------------------

- Director Joseph Gitto resigned from board and audit committee on May 6, 2024, effective immediately.
- Nasdaq notified company on May 8, 2024 of non-compliance with Listing Rule 5605 (majority independent board, three independent audit committee members).
- Cure period runs until earlier of next annual shareholders' meeting or May 6, 2025 (or November 4, 2024 if meeting before November 4, 2024).
- Company plans to appoint one or more independent directors to the board and audit committee within the cure period.
- Notice has no immediate effect on listing or trading of ICCT common stock on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906133/000147793224002686/0001477932-24-002686-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906133/000147793224002686/icct_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-002686

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer